Mark Weinberg

Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double‐blind, randomized, placebo‐controlled trial

Philip J. Mease, Dafna D. Gladman, Christopher T. Ritchlin et al. · Arthritis & Rheumatism · 2005 · 905 citations

Medicine, Pharmacology, Pharmacotherapy +15

Effect of Endothelin-A Receptor Blockade With Atrasentan on Tumor Progression in Men With Hormone-Refractory Prostate Cancer: A Randomized, Phase II, Placebo-Controlled Trial

Michael A. Carducci, Robert J. Padley, Jürgen Breul et al. · Journal of Clinical Oncology · 2003 · 370 citations

Medicine, Oncology, Pharmacology +16

Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome

Yu‐Tze Ng, Joan A. Conry, Rebecca Drummond et al. · Neurology · 2011 · 191 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Safety and efficacy of adalimumab in treatment of patients with psoriatic arthritis who had failed disease modifying antirheumatic drug therapy.

Mark C. Genovese, Philip J. Mease, G. T. D. Thomson et al. · PubMed · 2007 · 190 citations

Medicine, Pharmacology, Pharmacotherapy +17

IL17A/F nanobody sonelokimab in patients with plaque psoriasis: a multicentre, randomised, placebo-controlled, phase 2b study

Kim Papp, Mark Weinberg, A. O. Morris et al. · The Lancet · 2021 · 140 citations

Life Sciences, Dermatology, Immunology +14